EDS-HT and JHS: (i) EDS-HT and JHS are the same disorder in all circumstances; (ii) EDS-HT and JHS are partially overlapping conditions
and correspond to the same disorder in selected circumstances (e.g., familial cases); and (iii) EDS-HT and JHS are two distinct disorders.
Available literature however is scarce of data in support to any of the above hypotheses. 7 Because of this lack of evidence, we use the term JHS/EDS-HT throughout this review article.
A central defining feature of JHS/EDS-HT is generalized joint hypermobility (gJHM), which refers to the characteristic of being able to actively and/or passively move joints beyond normal limits. 9 Joint hypermobility can affect a few joints (localized or monoarticular joint hypermobility) or several joints in multiple body sites (gJHM).
Generalized joint hypermobility, in the absence of other symptoms, is considered to be a harmless trait and may even confer advantages for certain areas of endeavor such as ballet dancers and gymnasts.
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In Western populations, the prevalence of gJHM is in the order of 10-20%, and even higher rates have been described in Asian and African population groups. 11, 12 The reported population prevalence of JHS/ EDS-HT of 1:5000 suggests that the risk of developing the syndrome in an individual with gJHM is small.
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Generalized joint hypermobility can be screened for using a simple validated five-point questionnaire, but is formally evaluated using the Beighton score (see Table 1 ). The definitive diagnosis of JHS/ EDS-HT however requires additional criteria to be fulfilled. Whereas the Villefranche criteria (1997, Table 2 ) are traditionally used for the diagnosis of EDS-HT, JHS is diagnosed using the Brighton criteria (1998, Table 2 ). 14, 15 The reader can appreciate the considerable overlap between the two different diagnostic criteria. International consensus currently considers the Brighton criteria as an extension of the Villefranche criteria and is therefore more often applied in clinical practice. 1 In addition, the Brighton criteria are more suitable for assessing adults considering the natural loss of joint mobility by age, whereas the Villefranche criteria are more adequate for evaluating children and young adults. 9 However, more recently, the diagnostic criteria are being harmonized by a group of international experts and the new criteria are expected to be published toward the end of 2016.
Interestingly, JHS/EDS-HT has specifically been shown to be highly prevalent in patients with functional GI disorders (FGIDs), [3] [4] [5] 16, 17 which include irritable bowel syndrome (IBS) and functional dyspepsia (FD). Functional GI disorders are common, affecting up to 20% of the general population and accounting for more than one-third of gastroenterologists' workload in secondary care. 18 Although the severity of complaints varies, it has been demonstrated that FGIDs exert a marked socioeconomic burden through increased absenteeism and healthcare utilization. 19 An important aspect is the chronic character of complaints and significant comorbidities associated with FGID, for example, fibromyalgia, autonomic dysfunction, and psychopathology, which can have profound effects on quality of life in these patients. 20 It is tempting to assume that patients presenting with signs and symptoms representative of JHS/EDS-HT constitute a separate clinical subgroup of patients with FGIDs in whom therapeutic considerations may differ from those without JHS/EDS-HT. The aim of this review was to examine the nature of GI symptoms and their underlying pathophysiology in JHS/EDS-HT with a particular focus on the functional GI disorders encountered in these patients and to consider the clinical implications of the diagnosis for practicing clinicians.
| METHODS
Evidence to support this review was obtained from an electronic database search via PubMed using the following search Medical Subject
Key Points
• Previous studies have shown a remarkable association between functional gastrointestinal (GI) disorders and joint hypermobility syndrome (JHS)/Ehlers-Danlos syndrome hypermobility type (EDS-HT), suggesting that about 50% of patients with functional dyspepsia and 40%
of patients with irritable bowel syndrome have JHS/ EDS-HT.
• Patients with functional GI disorders who meet the criteria for JHS/EDS-HT may therefore represent a distinct phenotype but is probably under-recognized by gastroenterologists.
• We here provide a summary of the literature and formulate a number of hypotheses to explain this commonly observed association. We also give a clinical recommendation to practicing gastroenterologist with regard to the management of symptoms in patients with JHS/EDS-HT. were excluded from further analysis. Although these may also include patients with JHS/EDS-HT, this population was considered too heterogeneous, which could complicate the generalizability of results.
For the same reason, articles discussing different EDS subtypes than JHS/EDS-HT were excluded. Furthermore, case reports were excluded from analysis because we believe these might not give an appropriate representation of the JHS/EDS-HT population and only describe the most catastrophic phenotypes. We would, however, like to refer the reader to a recent review summarizing these papers. 21 All residual articles discussing GI manifestations in JHS/EDS-HT or JHS were further examined for useful references that did not emerge in the initial search. A total of 11 articles that focussed on GI manifestations in JHS/EDS-HT were selected for inclusion. One study found a high prevalence of gJHM in a pediatric population of patients with FGIDs; however, as it did not meet the inclusion criteria for the current manuscript, we have not provided further details. 22 Unfortunately, no studies discussing GI manifestations in pediatric JHS/EDS-HT patients were identified, limiting evidence of the current review to the adult population. In addition to the systematic search on the GI manifestations in JHS/EDS-HT as described above, we investigated current Beighton score (clinical assessment of joint hypermobility). Score 0-9.
1. Passive dorsiflexion of the little fingers beyond 90 degrees (one point for each hand). Two points 2. Passive apposition of the thumbs to the flexor aspects of the forearms (one point for each thumb). Two points 3. Hyperextension of the elbows beyond 10 degrees (one point for each elbow). Two points. 4. Hyperextension of the knees beyond 10 degrees (one point for each knee). Two points. 5. Forward flexion of the trunk with knees fully extended so that the palms of the hands rest flat on the floor. One point.
Brighton Classification for JHS
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Villefranche criteria for the EDS-HT literature to explore non-GI manifestations in JHS/EDS-HT in a narrative approach to merge parallel findings in order to offer a reasonable insight into pathogenesis.
| RESULTS
| JHS/EDS-HT and functional GI disorders
Several reports have been published to describe the putative relationship between JHS/EDS-HT and GI symptoms (see Table S1 ). clinic. 16 In addition, these patients were compared to patients who were referred from the rheumatology clinic with a previously confirmed diagnosis of JHS/EDS-HT and were characterized by higher prevalence of various musculoskeletal features and higher Beighton scores. A high prevalence of GI symptoms was found in all groups, although symptoms were most common in rheumatology referrals (see Table 3 ). Moreover, these patients were more likely to be diagnosed with a FGID (see Figure 2 ).
More recently, Fikree et al. prospectively examined the relationship between JHS/EDS-HT and FGIDs in a case-control design study comparing patients with a diagnosis of a FGID or an organic GI disorder. 17 There was a significantly higher prevalence of JHS/EDS-HT in the FGID group (39% versus 27.5%, P=.002). Interestingly, the prevalence of JHS/EDS-HT was 51% in patients with postprandial distress syndrome, a subtype of FD.
In 2013, Zeitoun et al. performed a cohort study of patients with EDS and found that gastro-esophageal reflux (heartburn and regurgitation) and dyspepsia (epigastric pain, nausea, postprandial fullness, and belching) were present in around 70% of the subjects. 5 Furthermore, 48% of all participants met criteria for IBS (using the Rome III criteria) and 36% had functional constipation. In addition, these authors reported a greatly reduced GI-related quality-of-life index.
More recently, Nelson et al. performed a retrospective review of patients diagnosed with EDS, of which 71% had JHS/EDS-HT. 4 Of 687 patients, 378 (55%) had GI symptoms, most notably abdominal pain (56%), nausea (44%), constipation (42%), heartburn (38%), irritable Reprinted from A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. CIs for proportions and ORs are presented in parentheses.
T A B L E 3 Comparison of prevalence of GI symptoms in non-JHS/EDS-HT patients, patients with JHS/EDS-HT from the unselected group, and patients with JHS/EDS-HT referred from rheumatology
Non-JHS/EDS-HT (CI) JHS/EDS-HT Unselected (CI) OR adjusted (CI) JHS/EDS-HT
From Clin Gastroenterol Hepatol. 2014;12
10
:1680-87, with permission from Elsevier.
F I G U R E 2
Prevalence of functional gastrointestinal disorders in non-JHS/EDS-HT patients, patients with JHS/EDS-HT from the unselected group, and patients with JHS/EDS-HT referred from rheumatology bowel-like symptoms (30%), vomiting (25%), and diarrhea (23% The finding of GI dysmotility in these patients is consistent with a previously observed high prevalence of dysmotility in patients with gJHM attending tertiary care neurogastroenterology clinics.
23 Table 4 shows a summary of prevalence data on GI symptoms in JHS/EDS-HT from the currently published studies. 
| JHS/EDS-HT and organic disorders 3.2.1 | Hiatus hernia
| Pelvic organ prolapse and defecatory disorders
Pelvic organ prolapse has been extensively investigated in the past, though mainly in gJHM. 25 One small study found a high prevalence 
| Celiac disease
One small study demonstrated that the prevalence of celiac disease was 16% in the JHS/EDS-HT group, which is significantly higher than the estimated population prevalence (1% Table S2 shows a summary of prevalence data on organic GI disor- healthy students who met criteria for JHS/EDS-HT were more likely to experience multiple GI symptoms in particular postprandial distress syndrome, as compared to healthy non-JHS/EDS-HT students.
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Finally, comparison of different studies is troublesome due to large differences in methodology (i.e., diagnostic criteria used, healthcare setting, and study design). We were therefore unable to perform a meta-analysis of data.
| Relevant non-GI manifestation in JHS/EDS-HT
There is growing evidence that patients with JHS/EDS-HT have an increased prevalence of chronic pain syndromes, autonomic dysfunction, and psychopathology. Because these factors are also comorbid with functional GI disorders, 32,33 the evidence for their involvement with JHS/EDS-HT will be described below.
| Chronic widespread pain and opiate use
A large survey conducted in the Netherlands among patients with EDS (including 157 with hypermobility subtype) showed that 98% of patients experienced chronic, mostly musculoskeletal pain. 
| Autonomic dysfunction
Patients with joint hypermobility syndrome/EDS-HT can experience symptoms suggestive of (pre)syncope (i.e., light-headedness, dizziness, and actual fainting), and palpitations and chest pain. Hakim and Grahame reported symptoms of presyncope in 41% of patients with JHS/EDS-HT, compared with only 15% in the control group.
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A subset of these symptoms may be explained by the association of JHS/EDS-HT with postural tachycardia syndrome (PoTS). Postural tachycardia syndrome is defined as an elevation of the heart rate of at least 30 bpm within 10 min after standing upright, or a heart rate >120 bpm after standing. The prevalence of PoTS in patients with JHS/EDS-HT reached 15% in one study. 41 Autonomic dysfunction, such as PoTS, orthostatic hypotension, and/or uncategorized orthostatic intolerance are seen in three of four patients with JHS/ EDS-HT. 42 Postural tachycardia syndrome can be treated with a combination of non-pharmacological approaches, a structured exercise training program, and often some pharmacological support. Several hypotheses have been formulated to explain why orthostatic intolerance is so strongly associated with JHS/EDS-HT. These include among others, altered vascular tissue elasticity, impaired peripheral vasoregulation, physical deconditioning, and neuropathies. 40, 43, 44 Postural tachycardia syndrome, independent of EDS status, is associated with GI symptoms and with dysmotility of the stomach, small bowel, and colon, as demonstrated by a number of previous studies. [45] [46] [47] Patients with GI symptoms who meet the criteria for JHS/ EDS-HT have significantly higher autonomic scores for orthostatic domains (P<.001) compared to patients without JHS/EDS-HT. 
| Psychiatric comorbidity
Since the late 80s, anxiety disorder has been described to appear more commonly in individuals with gJHM. 48 More recently, these associations have also been found in patients with JHS/EDS-HT, as extensively reviewed by Sinibaldi et al. 49 Furthermore, panic disorder, agoraphobia, simple phobia, and dysthymic disorder or major depression were all found to have a strong association with JHS/EDS-HT.
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A 15-year follow-up cohort study of patients with JHS/EDS-HT showed a cumulative incidence of panic disorder of 41.4% in the JHS/ EDS-HT group, compared with only 1.9% in the non-JHS/EDS-HT control group.
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The observed prevalence of anxiety and other psychiatric comorbidities is higher in JHS/EDS-HT than other chronic pain conditions, but the basis for this is not fully understood. 52 Several studies have hypothesized this to be related to increased interoception, which refers to the concept of sensory bodily information that is continuously assessed and interpreted in relation to certain expectations, which results in a person becoming aware of his/her autonomic bodily state. This interoceptive sensitivity enhances the salience of previously innocuous stimuli, meaning that bodily prediction error signals (e.g., increased heart rate) are attributed to ambiguous environmental stimuli, which in turn become potential threats. 53 Interoceptive sensitivity can be associated with enhanced emotional responsiveness resulting in anxiety and hypervigilance. 54 It has been confirmed through questionnaires that people with gJHM score higher on a body awareness index, 55 a factor which can contribute to the development of anxiety.
Other possible hypotheses put forward to explain the increased psychiatric manifestations in JHS/EDS-HT include the fact that a greater perception of joint instability and the frequency with which this impacts on activities of daily living can contribute to anxiety.
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Furthermore, frequent falling due to autonomic dysfunction can sometimes result in kinesiophobia (fear of movement)-an excessive, irrational, and debilitating fear of physical movement and activity resulting from a feeling of vulnerability to painful injury or re-injury.
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In addition, a considerable phenomenological overlap exists between symptoms of both PoTS and anxiety (i.e., panic, dizziness, palpitations) and it is possible that these symptoms of orthostatic intolerance may exacerbate anxiety, particularly so when combined with enhanced interoception.
A recent study demonstrated a significant association of abdominal, joint, and neuropathic pain with having a psychiatric disorder in EDS. 57 However, other GI manifestations, notably symptoms of dyspepsia and reflux, were not significantly affected by the presence of psychopathology. 16 This would suggest that the contribution of psychopathology to GI manifestations in JHS/EDS-HT may be symptom dependent and primarily related to pain.
| DISCUSSION
Scientific evidence suggests an association between JHS/EDS-HT and GI disorders, and these patients meet the criteria for FGIDs, specifically those with upper GI symptoms. 4, 5, 16, 17 Interestingly, postprandial distress syndrome, a subtype of dyspepsia, showed the strongest association with JHS/EDS-HT in one study, 17 and symptoms of this disorder including bloating and postprandial fullness were consistently associated with JHS/EDS-HT in multiple studies (see Table 4 ), but the etiology behind this remains to be elucidated. Another important observation is that patients with JHS/EDS-HT with lower Beighton scores and modest musculoskeletal involvement seem to experience fewer GI symptoms. 16 It could be speculated that these patients would have a better prognosis concerning GI symptoms compared with their more hypermobile peers, although this hypothesis will need to be assessed in future studies.
The prerequisite step to the development of a more complete understanding of the relationship between JHS/EDS-HT and GI symptoms is the objective assessment as to whether such symptoms are attributable to any demonstrable physiological or anatomical abnormalities therein. It should be noted that, to date, only a preliminary study has examined this specifically. In this study, esophageal motility was evaluated in 17 JHS/EDS-HT with dysphagia symptoms. This study, as of yet available in abstract form, has shown that 59% (10/17) of patients had evidence of esophageal dysmotility. 58 No other stud- Sensitization refers to a reduction in the threshold for perception of sensory stimuli arising from visceral organs. A commonly accepted hypothesis in the development of functional GI disorders is indeed related to visceral hypersensitivity. 65 We therefore speculate that neurodevelopmental changes as a result of ECM abnormalities in JHS/ EDS-HT may render intestinal afferents more prone to sensitization.
However, no studies have specifically examined the presence of visceral hypersensitivity in JHS/EDS-HT, let alone to establish whether this is related to alterations in afferent signaling. 
| CONCLUSIONS AND RECOMMENDATIONS FOR CLINICAL PRACTICE
We here provide recommendation for the clinical management of patients with JHS/EDS-HT presenting with GI symptoms, which are based on expert opinion rather than scientific evidence due to the current paucity of data.
1.
Recognition. It is important for gastroenterologists to consider the diagnosis of JHS/EDS-HT in patients with FGIDs and multiple musculoskeletal symptoms. When JHS/EDS-HT is suspected, the patient should be referred to a specialist that is familiar with the disorder (i.e., clinical geneticist or rheumatologist) in order to establish a definitive diagnosis. It is of interest that despite extensive advances in our understanding of gut sensorimotor function, the aspect that is least studied is the role of connective tissue in gut function. Not very long agoagainst all odds-Helicobacter pylori was found to be the cause for peptic ulcer disease. Time will tell whether the putative association between JHS/EDS-HT and FGIDs has a similar potential within neurogastroenterology.
F I G U R E 3 Diagram illustrating possible pathways for the pathogenesis of functional gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type
